<DOC>
	<DOCNO>NCT01642550</DOCNO>
	<brief_summary>The purpose study determine administration RM-131 effective improve appetite gastrointestinal symptom leading recovery patient anorexia nervosa outpatient setting .</brief_summary>
	<brief_title>Phase 2 Pilot Study Evaluate Safety Efficacy RM-131 Administered Females With Anorexia Nervosa</brief_title>
	<detailed_description />
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<criteria>DSMIV criterion anorexia nervosa , include weight &lt; 85 % ideal body weight ( IBW ) amenorrhea three month ; Age 1845 year old ; Gastrointestinal tract symptom ; Nonhormonal method birth control , must use throughout study . Female patient unable bear child must document ( i.e. , tubal ligation , hysterectomy , postmenopausal , define minimum one year since last menstrual period elevate FSH ) ; Stable concomitant medication define change regimen least 2 week prior baseline ; Able provide write informed consent prior study procedure willing able comply study procedure , include daily SC injection completion daily injection log . Patient primary care physician treatment team manage care . Use hormone therapy ( include limit estrogen , progesterone ) hormonal method birth control ( i.e. , oral , implantable , injectable ) within eight week screen ; DepoProvera within six month screen ; Pregnancy , lactation breastfeeding , positive serum urine pregnancy test , within eight week screen ; History diabetes mellitus ; History purge behavior great monthly within last three month ; Active substance abuse ; Use metoclopramide , erythromycin , 5HT3 antiemetic , opioid medication within 2 week prior baseline . [ Note : drug also use postbaseline ] ; Hematocrit &lt; 30.0 % , hemoglobin &lt; 10.0 g/dl , potassium &lt; 3.0 mmol/L , fast glucose &gt; 100 mg/dL , creatinine &gt; 1.5 mg/dL , AST ALT &gt; 1.5 time upper limit normal , abnormal plasma thyroid stimulate hormone ( TSH ) level ; Currently receive parenteral feed enteral feeding , presence nasogastric enteral tube feed decompression ; History gastric surgery fundoplication , gastrectomy , gastric pacemaker placement , vagotomy , bariatric procedure , small large bowel resection ; Clinical suspicion , opinion investigator , active symptomatic peptic ulcer disease , cholelithiasis , colitis , celiac sprue , inflammatory bowel disease ; Active suicidal ideation ; Beck Depression Inventory2 score â‰¥ 29 ; Current inpatient hospitalization ; Allergic intolerant egg , milk , wheat algae , component GEBT test meal ; Participation clinical study investigational medication device within 30 day prior dose present study ; Any reason , opinion Investigator , include severe renal , hepatic cardiac disease , would confound proper interpretation study expose patient unacceptable risk .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Anorexia nervosa</keyword>
	<keyword>Anorexia</keyword>
	<keyword>Eating disorder</keyword>
</DOC>